THAINá Rodrigues, PATRíCIA Candido, Feres Camargo Maluf, Poliana ROMãO, Carolina Mie Mioshi, Vanessa Ribeiro GUIMARãES, Juliana Alves DE Camargo, Karina Serafim DA Silva, Gabriel Arantes Dos Santos, Iran Amorim Silva, Katia Ramos Moreira Leite, William C Nahas, Sabrina T Reis, Ruan Pimenta, Nayara Izabel Viana
{"title":"Is miR-10a a tumor suppressor that modulates proliferation and invasion in high-grade bladder cancer?","authors":"THAINá Rodrigues, PATRíCIA Candido, Feres Camargo Maluf, Poliana ROMãO, Carolina Mie Mioshi, Vanessa Ribeiro GUIMARãES, Juliana Alves DE Camargo, Karina Serafim DA Silva, Gabriel Arantes Dos Santos, Iran Amorim Silva, Katia Ramos Moreira Leite, William C Nahas, Sabrina T Reis, Ruan Pimenta, Nayara Izabel Viana","doi":"10.32604/or.2025.055306","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Bladder Cancer (BC) is one of the most commonly diagnosed malignancies worldwide, with high rates of mortality and morbidity. It can be classified as non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC), with radical cystectomy being the treatment for MIBC, which significantly reduces quality of life. MicroRNAs (miRs) act as critical genetic regulators, with both oncogenic and tumor-suppressive roles. MiR-10a is described as a tumor suppressor in various neoplasms, but its role in BC is controversial. This study aims to assess the activity of miR-10a in cellular invasion and proliferation in two distinct BC cell lines.</p><p><strong>Methods: </strong>The study used high-grade T24 and low-grade RT4 bladder cell lines. Cells were transfected with miR-10a mimic or a non-targeting control. Transfection efficiency was validated by qPCR. Cell proliferation was cultured for 10-14 days. Cell migration and invasion were evaluated using Matrigel. All assays were conducted in triplicate.</p><p><strong>Results: </strong>The T24 cells transfected with miR-10a presented decreased cellular proliferation and invasion compared to the Scramble (<i>p</i> = 0.0481 and <i>p</i> < 0.0001, respectively). In the RT4 cell line, there was only a significant reduction in cellular proliferation after miR-10a transfection (<i>p</i> = 0.0029). <b>Conclusions:</b> Our findings suggest that miR-10a has a tumoral suppressor role in BC, demonstrating higher efficacy in high-grade cells.</p>","PeriodicalId":19537,"journal":{"name":"Oncology Research","volume":"33 6","pages":"1377-1382"},"PeriodicalIF":4.1000,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12144657/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.32604/or.2025.055306","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Bladder Cancer (BC) is one of the most commonly diagnosed malignancies worldwide, with high rates of mortality and morbidity. It can be classified as non-muscle invasive bladder cancer (NMIBC) or muscle-invasive bladder cancer (MIBC), with radical cystectomy being the treatment for MIBC, which significantly reduces quality of life. MicroRNAs (miRs) act as critical genetic regulators, with both oncogenic and tumor-suppressive roles. MiR-10a is described as a tumor suppressor in various neoplasms, but its role in BC is controversial. This study aims to assess the activity of miR-10a in cellular invasion and proliferation in two distinct BC cell lines.
Methods: The study used high-grade T24 and low-grade RT4 bladder cell lines. Cells were transfected with miR-10a mimic or a non-targeting control. Transfection efficiency was validated by qPCR. Cell proliferation was cultured for 10-14 days. Cell migration and invasion were evaluated using Matrigel. All assays were conducted in triplicate.
Results: The T24 cells transfected with miR-10a presented decreased cellular proliferation and invasion compared to the Scramble (p = 0.0481 and p < 0.0001, respectively). In the RT4 cell line, there was only a significant reduction in cellular proliferation after miR-10a transfection (p = 0.0029). Conclusions: Our findings suggest that miR-10a has a tumoral suppressor role in BC, demonstrating higher efficacy in high-grade cells.
期刊介绍:
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.